GVR Report cover MEA Hip And Knee Reconstruction Devices Market Size, Share & Trends Report

MEA Hip And Knee Reconstruction Devices Market Size, Share & Trends Analysis Report By Technique (Joint Replacement, Osteotomy, Arthroscopy, Resurfacing, Arthrodesis), By Country, And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-4-68039-433-5
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Market Size & Trends

The MEA hip and knee reconstruction devices market size was estimated at USD 3.62 billion in 2024 and is projected to grow at a CAGR of 5.2% from 2025 to 2030. The increasing prevalence of orthopedic conditions, particularly knee osteoarthritis, which is spurring demand for joint replacement surgeries across the region, is driving market growth worldwide. The aging population, with countries such as South Africa reporting high rates of osteoarthritis, necessitates a proactive approach towards orthopedic interventions. This rising demand signifies a critical need for advanced reconstruction devices that can meet the growing challenges posed by these orthopedic disorders.

MEA Hip And Knee Reconstruction Devices Market Size, by Technique, 2020 - 2030 (USD Billion)

Technological advancements play a pivotal role in shaping the future of the hip and knee reconstruction devices market. Innovations such as minimally invasive surgical techniques, advanced implant designs, and the integration of 3D printing technologies are transforming surgical practices and improving patient outcomes. Personalized implants tailored to individual anatomical needs not only enhance the effectiveness of procedures but also elevate patient satisfaction. As healthcare stakeholders prioritize safety and efficacy, these technological developments are set to determine the competitive edge in the market.

The incidence of lifestyle disorders, particularly obesity, is also driving market growth. With rising obesity rates in multiple MEA countries, the demand for orthopedic interventions is anticipated to increase, as obesity is a well-documented risk factor for various joint conditions. As healthcare providers recognize the link between lifestyle and orthopedic health, targeted initiatives to mitigate these disorders are likely to amplify the need for reconstruction devices in the region. Consequently, in November 2023, Aman Hospital pioneered Qatar’s first minimally invasive hip and knee replacement, led by Dr. Feras Ashouri, enabling rapid recovery and elevating healthcare standards in the region.

Investment in healthcare infrastructure across the MEA region continues to enhance access to surgical procedures and rehabilitation services. This commitment to improving healthcare standards is expected to yield better surgical outcomes and patient care, further promoting the adoption of reconstruction devices. In tandem with an increase in patient awareness and acceptance of joint surgeries, these factors are establishing a robust framework for sustained growth in the hip and knee reconstruction devices market in the Middle East and Africa.

Technique Insights

Joint replacement led the market with a revenue share of 25.4% in 2024, driven by the rising prevalence of orthopedic conditions such as osteoarthritis, which require surgical intervention. Furthermore, advancements in surgical methodologies, coupled with an aging population, are significant contributors to segment growth.

Arthrodesis is expected to grow at the fastest CAGR of 5.3% over the forecast period, fueled by its efficacy in addressing severe joint pain and instability. As orthopedic conditions such as arthritis become more widespread, patients are increasingly pursuing surgical options that offer long-term relief and enhanced functionality, thereby enhancing the appeal of this technique.

Country Insights

South Africa hip and knee reconstruction devices market dominated the Middle East & Africa market with a revenue share of 12.3% in 2024. The country is witnessing a high prevalence of osteoarthritis among its aging population. Contributing factors include increased healthcare investments and advancements in surgical techniques, which are enhancing the demand for effective joint replacement solutions. This positions South Africa as a leader within the MEA region for orthopedic interventions.

MEA Hip And Knee Reconstruction Devices Market Share, by Country, 2024 (%)

The hip and knee reconstruction devices market in Israel is expected to grow at the fastest rate of 5.8% over the forecast period, supported by escalating obesity rates that heighten the need for joint surgeries. Moreover, continuous investments in healthcare infrastructure and the introduction of innovative products by key industry players are expanding treatment options, further propelling market growth within the region.

Key MEA Hip And Knee Reconstruction Devices Company Insights

Some key companies operating in the market include Enovis; Smith+Nephew; Zimmer Biomet; B. Braun SE; CONMED Corporation. Strategic initiatives encompass product launches, geographic expansions, and collaborations designed to improve market penetration and meet the increasing demand for innovative orthopedic solutions in the region.

  • Smith+Nephew provides innovative orthopedic solutions, including hip and knee implants, robotic-assisted technologies, and trauma products. Their state-of-the-art offerings are designed to enhance surgical precision and improve patient outcomes.

  • B. Braun SE offers a diverse portfolio that includes surgical instruments and implants. The company is dedicated to enhancing surgical efficiency and patient safety through its innovative solutions.

Key MEA Hip And Knee Reconstruction Devices Companies:

The following are the leading companies in the MEA hip and knee reconstruction devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Enovis
  • Smith+Nephew
  • Zimmer Biomet
  • B. Braun SE
  • CONMED Corporation
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • Meril Life Sciences Pvt. Ltd.
  • Arthrex, Inc.

Recent Developments

  • In December 2024, Zimmer Biomet announced FDA clearance for the Persona SoluTion PPS Femur, providing a cementless knee implant alternative for patients with sensitivities to bone cement and metal.

  • In January 2024, Fortius Clinic showcased advanced robotic technology for hip and knee replacement surgery at Arab Health 2024, enhancing surgical precision and promoting faster recovery for patients with chronic joint issues.

MEA Hip And Knee Reconstruction Devices Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 3.81 billion

Revenue forecast in 2030

USD 4.90 billion

Growth rate

CAGR of 5.2% from 2025 to 2030

Base year for estimation

2024

Historical data

2018 - 2023

Forecast period

2025 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Technique, country

Regional scope

MEA

Country scope

South Africa, Saudi Arabia, Israel, Egypt, Oman, Kuwait, Bahrain, Lebanon, Qatar, Iran

Key companies profiled

Enovis; Smith+Nephew; Zimmer Biomet; B. Braun SE; CONMED Corporation; DePuy Synthes (Johnson & Johnson Services, Inc.); Meril Life Sciences Pvt. Ltd.; Arthrex, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

MEA Hip And Knee Reconstruction Devices Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the MEA hip and knee reconstruction devices market report based on technique, and country:

  • Technique Outlook (Revenue, USD Million, 2018 - 2030)

    • Joint Replacement

      • Implants

      • Bone Graft

        • Allograft

        • Synthetic

    • Osteotomy

    • Arthroscopy

    • Resurfacing

    • Arthrodesis

    • Others

  • Country Outlook (Revenue, USD Million, 2018 - 2030)

    • South Africa

    • Saudi Arabia

    • Israel

    • Egypt

    • Oman

    • Kuwait

    • Bahrain

    • Lebanon

    • Qatar

    • Iran

Frequently Asked Questions About This Report

pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.